Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays

Journal of Clinical Microbiology

Volumn 37, Issue 1, 1999, Pages 49-55

  Troesch, A ^a,b   Nguyen, H ^b   Miyada, C G ^b   Desvarenne, S ^a   Gingeras, T R ^b   Kaplan, P M ^b   Cros, P ^a   Mabilat, C ^a  

^a BIOMÉRIEUX   (France)

^b Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; DNA PROBE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0032956681     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.1.49-55.1999     Document Type: Article

References (31)

1. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, S. K. Um, T. Wilson, D. Collins, G. De Lisle, and W. R. Jacobs. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
2. Böddinghaus, B., T. Rogall, T. Flohr, H. Blöcker, and E. C. Böttger. 1990. Detection and identification of mycobacteria by amplification of rRNA. J. Clin. Microbiol. 28:1751-1759.
3. Chee, M., R. Yang, E. Hubbell, A. Berno, X. C. Huang, D. Stern, J. Winkler, D. J. Lockhart, M. S. Morris, and S. P. A. Fodor. 1996. Accessing genetic information with high-density DNA arrays. Science 274:610-614.
4. Cole, S. T. 1994. Mycobacterium tuberculosis: drug-resistance mechanisms. Trends Microbiol. 2:411-415.
5. Cooksey, R. C., G. P. Morlock, S. Glickman, and J. T. Crawford. 1997. Evaluation of a Line Probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol. 35:1281-1283.
6. Cronin, M. T., R. V. Fucini, S. M. Kim, R. S. Masino, R. M. Wespi, and C. G. Miyada. 1996. Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays. Hum. Mutat. 7:244-255.
7. Fodor, S. P. A., R. P. Rava, X. C. Huang, A. C. Pease, C. P. Holmes, and C. L. Adams. 1993. Multiplexed biochemical assays with biological chips. Nature 364:555-556.
8. Gingeras, T. R., G. Ghandour, E. Wang, A. Berno, P. M. Small, F. Drobniewski, D. Alland, E. Desmond, M. Holodniy, and J. Drenkow. 1998. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res. 8:435-448.
9. Heym, B., P. M. Alazari, N. Honoré, and S. T. Cole. 1995. Missense mutations in catalase-peroxidase gene, katG, are associated with isoniazid-resistance in Mycobacterium tuberculosis. Mol. Microbiol. 15:235-245.
10. Horsburgh, C. R. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:1332-1338.
11. Jenkins, P. A. 1991. Mycobacteria in the environment. J. Appl. Bacteriol. Symp. 70(Suppl.):137S-141S.
12. Kapur, V., L. L. Li, S. Iordanescu, M. R. Hamrik, A. Wanger, B. N. Kreiswirth, and J. M. Musser. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
13. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, publication no 86-8230. U.S. Department of Health and Human Services, Washington, D.C.
14. Kirschner, P., B. Springer, U. Vogel, A. Meier, A. Wrede, M. Kiekenbeck, F. C. Bange, and E. C. Böttger. 1993. Genotypic identification of mycobacteria by nucleic acids sequence determination: report of a 2-year experience in a clinical laboratory. J. Clin. Microbiol. 31:2882-2889.
15. Kirschner, P., J. Rosenau, B. Springer, K. Teschner, K. Feldmann, and E. C. Böttger. 1996. Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study. J. Clin. Microbiol. 34:304-312.
16. Koukila-Kahkola, P., B. Springer, E. C. Böttger, L. Paulin, E. Jantzen, and M. L. Katila. 1995. Mycobacterium branderi sp. nov., a new potential human pathogen. Int. J. Syst. Bacteriol. 45:549-553.
17. Kozal, M. J., N. Shah, N. Shen, R. Yang, R. Fucini, T. C. Merigan, D. D. Richman, D. Morris, E. Hubbell, M. Chee, and T. R. Gingeras. 1996. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat. Med. 2:753-759.
18. Lockhart, D. J., H. Dong, M. C. Byrne, M. T. Follettie, M. V. Gallo, M. S. Chee, M. Mittman, C. Wang, M. Kobayashi, H. Horton, and E. L. Brown. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14:1675-1680.
19. Mdluli, K., R. A. Slayden, Y. Zhu, S. Ramaswamy, X. Pan, D. Mead, D. D. Crane, J. M. Musser, and C. E. Barry III. 1998. Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science 280:1607-1610.
20. Raviglíone, M. C., D. E. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
21. Roberts, G. D., E. W. Koneman, and Y. K. Kim. 1991. Mycobacterium, p. 304-339. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
22. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculosis drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
23. Springer, B., L. Stockman, K. Teschner, G. D. Roberts, and E. C. Böttger. 1996. Two-laboratory collaborative study on identification of mycobacterta: molecular versus phenotypic methods. J. Clin. Microbiol. 34:296-303.
24. Sreevatsan, S., X. Pan, Y. Zhang, B. N. Kreiswirth, and J. M. Musser. 1997. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob. Agents Chemother. 41: 636-640.
25. Sreevatsan, S., K. E. Stockbauer, X. Pan, B. N. Kreiswirth, S. L. Moghazeh, W. R. Jacobs, Jr., A. Telenti, and J. M. Musser. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother. 41:1677-1681.
26. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. T. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rflampin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
27. Tortoli, E., C. Piersimoni, P. Kirschner, A. Bartoloni, C. Burrini, C. Lacchini, A. Mantella, G. Muzzi, C. Passerini Tosi, V. Penati, C. Scarparo, M. Tullia Simonetti, and E. C. Böttger. 1997. Characterization of niycobacterial isolates phylogenetically related to, but different from, Mycobacterium simiae. J. Clin. Microbiol. 35:697-702.
28. Whelen, A. C., T. A. Felmlee, J. M. Hunt, D. L. Williams, G. D. Roberts, L. Stockman, and D. H. Persing, 1995. Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J. Clin. Microbiol. 33:556-561.
29. Wilson, T. M., and D. M. Collins. 1996. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbiol. 19: 1025-1034.
30. Yates, M. D., A. Pozniak, A. H. C. Uttley, R. Clarke, and J. M. Grange. 1997. Isolation of environmental mycobacteria from clinical specimens in southeast England: 1973-1993. Int. J. Tuberc. Lung Dis. 1:75-80.
31. Zhang, Y., B. Heym, B. Allen, D. Young, and S. T. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:501-503.